Literature DB >> 1991635

Dissociation between systemic and mucosal humoral immune responses in coeliac disease.

S O'Mahony1, E Arranz, J R Barton, A Ferguson.   

Abstract

We examined humoral immunity in coeliac disease as expressed in serum (systemic immunity), and in saliva, jejunal aspirate, and whole gut lavage fluid (mucosal immunity). The aims were to define features of the secretory immune response (IgA and IgM concentrations and antibody values to gliadin and other food proteins measured by enzyme linked immunosorbent assay (ELISA)) in active disease and remission, and to establish whether secretions obtained by relatively non-invasive techniques (saliva and gut lavage fluid) can be used for indirect measurements of events in the jejunum. Serum, saliva, and jejunal aspirate from 26 adults with untreated coeliac disease, 22 treated patients, and 28 immunologically normal control subjects were studied, together with intestinal secretions obtained by gut lavage from 15 untreated and 19 treated patients with coeliac disease and 25 control subjects. Jejunal aspirate IgA and IgM and gut lavage fluid IgM concentrations were significantly raised in patients with untreated coeliac disease; the lavage fluid IgM concentration remained higher in patients with treated coeliac disease than in controls. Serum and salivary immunoglobulin concentrations were similar in the three groups. Patients with untreated coeliac disease had higher values of antibodies to gliadin compared with treated patients and control subjects in all body fluids tested; these were predominantly of IgA and IgG classes in serum, and of IgA and IgM classes in jejunal aspirate and gut lavage fluid. Values of salivary IgA antibodies to gliadin were significantly higher in untreated coeliacs, though antibody values were generally low, with a large overlap between coeliac disease patients and control subjects. In treated patients, with proved histological recovery on gluten free diet, serum IgA antigliadin antibody values fell to control values, though serum IgG antigliadin antibody values remained moderately raised. In contrast, there was persistence of secretory antigliadin antibodies in treated patients (particularly IgM antibody) in both jejunal aspirate and gut lavage fluid. Antibody responses to betalactoglobulin and ovalbumin were similar to those for gliadin, including persistence of high intestinal antibody values in patients with treated coeliac disease. There was a positive correlation between antibody values in jejunal aspirate and gut lavage fluid, but not between saliva and jejunal aspirate; thus salivary antibodies do not reflect intestinal humoral immunity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1991635      PMCID: PMC1379209          DOI: 10.1136/gut.32.1.29

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  19 in total

1.  Gluten-sensitive enteropathy: synthesis of antigliadin antibody in vitro.

Authors:  Z M Falchuk; W Strober
Journal:  Gut       Date:  1974-12       Impact factor: 23.059

Review 2.  The common mucosal immune system and current strategies for induction of immune responses in external secretions.

Authors:  J Mestecky
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

3.  Cell-mediated immunity to gluten fraction III in adult coeliac disease.

Authors:  A W Bullen; M S Losowsky
Journal:  Gut       Date:  1978-02       Impact factor: 23.059

4.  IgA anti-gliadin antibodies in coeliac disease.

Authors:  D J Unsworth; M Kieffer; E J Holborow; R R Coombs; J A Walker-Smith
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

5.  Immunoglobulins in jejunal mucosa and serum from patients with adult coeliac disease.

Authors:  K Baklien; P Brandtzaeg; O Fausa
Journal:  Scand J Gastroenterol       Date:  1977       Impact factor: 2.423

6.  A method of obtaining, processing, and analyzing human intestinal secretions for antibody content.

Authors:  M M Gaspari; P T Brennan; S M Solomon; C O Elson
Journal:  J Immunol Methods       Date:  1988-05-25       Impact factor: 2.303

7.  Jejunal plasma cells and in vitro immunoglobulin production in adult coeliac disease.

Authors:  G M Wood; P D Howdle; L K Trejdosiewicz; M S Losowsky
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

8.  Precipitins to dietary proteins in serum and upper intestinal secretions of coeliac children.

Authors:  A Ferguson; F Carswell
Journal:  Br Med J       Date:  1972-01-08

9.  Intestinal and serum antibody in coeliac disease: a comparison using ELISA.

Authors:  J T Labrooy; A W Hohmann; G P Davidson; P A Hetzel; R B Johnson; D J Shearman
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

10.  Cell-mediated immunity to gliadin within the small-intestinal mucosa in coeliac disease.

Authors:  A Ferguson; T T MacDonald; J P McClure; R J Holden
Journal:  Lancet       Date:  1975-04-19       Impact factor: 79.321

View more
  27 in total

1.  Serological markers and HLA-DQ2 haplotype among first-degree relatives of celiac patients. Catalonian Coeliac Disease Study Group.

Authors:  C Farré; P Humbert; P Vilar; V Varea; X Aldeguer; J Carnicer; M Carballo; M A Gassull
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

2.  Gut lavage IgG and interleukin 1 receptor antagonist:interleukin 1 beta ratio as markers of intestinal inflammation in children with inflammatory bowel disease.

Authors:  R Troncone; N Caputo; A Campanozzi; M Cucciardi; V Esposito; R Russo; B De Vizia; L Greco; S Cucchiara
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

3.  Anti-endomysial antibody negative celiac disease: does additional serological testing help?

Authors:  A Dahele; K Kingstone; J Bode; D Anderson; S Ghosh
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

4.  Class and subclass-associated specificity differences of anti-gliadin antibodies from mucosa and serum.

Authors:  P E Engström; U Sundin; B Lavö; G Norhagen; R Hällgren; C I Smith; L Hammarström
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

5.  Salivary IgA from the sublingual compartment as a novel noninvasive proxy for intestinal immune induction.

Authors:  A Aase; H Sommerfelt; L B Petersen; M Bolstad; R J Cox; N Langeland; A B Guttormsen; H Steinsland; S Skrede; P Brandtzaeg
Journal:  Mucosal Immunol       Date:  2015-10-28       Impact factor: 7.313

6.  Immunosenescence and mucosal immunity: significant effects of old age on secretory IgA concentrations and intraepithelial lymphocyte counts.

Authors:  E Arranz; S O'Mahony; J R Barton; A Ferguson
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

7.  Smoking, humoral immunity, and ulcerative colitis.

Authors:  E D Srivastava; J R Barton; S O'Mahony; D I Phillips; G T Williams; N Matthews; A Ferguson; J Rhodes
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

8.  The anti-transglutaminase auto-antibodies in children's saliva with a suspect coeliac disease: clinical study.

Authors:  R Condò; M Costacurta; R Docimo
Journal:  Oral Implantol (Rome)       Date:  2013-10-15

9.  Phage display of human antibodies from a patient suffering from coeliac disease and selection of isotype-specific scFv against gliadin.

Authors:  Claudio Rhyner; Michael Weichel; Philipp Hübner; Gernot Achatz; Kurt Blaser; Reto Crameri
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

10.  Two-dimensional gel proteome reference map of human small intestine.

Authors:  Maria Paola Simula; Renato Cannizzaro; Maria Dolores Marin; Alessandro Pavan; Giuseppe Toffoli; Vincenzo Canzonieri; Valli De Re
Journal:  Proteome Sci       Date:  2009-03-19       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.